ESSA Pharma News

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BB Biotech AG(0.0%),Biotech Growth N.V. N/A(0.0%)

Nov 14 19:37 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PFM Health Sciences, LP(6.2%),PFM Health Sciences GP, LLC(6.2%), etc.

Nov 14 17:23 ET

ESSA Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(7.4%),Roderick Wong, M.D.(7.4%)

Nov 14 07:02 ET

ESSA Pharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL MANAGEMENT, LLC(9.7%),KEVIN TANG(9.7%), etc.

Nov 8 17:00 ET

ESSA Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BML Investment Partners, L.P.(9.4%)

Nov 7 12:54 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner BIOTECH GROWTH N V

Nov 5 12:11 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

Oct 7 15:03 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

Sep 9 14:05 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

Sep 3 19:02 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

May 6 17:21 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Glickman Richard M

Apr 25 10:40 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Virsik Peter

Apr 5 18:19 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director ZWEIFACH SANFORD S

Mar 28 12:45 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Thorell Marella

Mar 28 12:45 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Sollis Gary

Mar 28 12:44 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Requadt Scott

Mar 28 12:40 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Merendino Lauren

Mar 28 12:40 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Martin John Alexander

Mar 28 12:40 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kantoff Philip W.

Mar 28 12:40 ET

ESSA Pharma | 4: Statement of changes in beneficial ownership of securities-Director Glickman Richard M

Mar 28 12:34 ET